Editorial: Contemporary quality‐of‐life scores provide a key foundation for high‐quality cancer research
Prostate cancer is the most common male malignancy in many countries, including the UK/Northern Ireland. Given excellent oncological outcomes for appropriately treated localised cancer, there is an increasing focus on understanding the quality‐of‐life implications of different treatment options. As Donnelly et al. [1] emphasise, contemporary cohorts of untreated men can provide useful comparisons for inferring the […]